Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Crestor NDA Includes Rhabdomyolysis Reports At Highest Dose

Dec 10 2001

• By The Pink Sheet

Related Content

Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?

Aug 13 2001

AstraZeneca To "Go It Alone" For Crestor, Cites Large Market Opportunity

Jul 30 2001

FDA “Approvable” Actions Increasing Under PDUFA, Agency Acknowledges

Nov 19 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window